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Abstract
Background: Chewing fresh leaves of the khat plant (Catha edulis forsk) is a deep rooted and widespread habit
in East Africa and the Middle East. Although a body of knowledge exists about the adverse effects of khat on
health, data are sparse with regard to the consequences of long-term khat chewing in resulting schizophrenic
like symptoms.
Methods: A crude extract of khat at different doses (100 mg/kg (K (khat)100), 200 mg/kg (K200) and 400 mg/kg
(K400)) were administered for experimental group of mice whereas standard (ketamine (KT) 10 mg/kg- positive
controls (KT10)) and vehicle (2 % v/v Tween-80 in distilled water – negative control groups (CON)) were administered
for control groups of mice daily for two months to evaluate subchronic oral administration of crude khat extract to
induce schizophrenic-like symptoms in mice. Mice were subjected to a battery of behavioural tests and parameters
like locomotor activity, total time spent in social interaction and level of cognition among different groups of mice
were measured and analyzed.
Results: Khat at all doses significantly increased (p < 0.001) the mean locomotor activity score of mice compared
to CON. However, the mean locomotor activity score of mice treated with khat was significantly lower (p < 0.001)
compared to the mean locomotor activity score of KT10 mice (p < 0.001).
The mean total time score (in seconds) spent in social interaction, mean total time score (in seconds) spent in sniffing
and following the partner was significantly higher (p < 0.001) in CON groups of mice compared to khat and ketamine
treated groups. Moreover, in spatial memory task, the mean latency score (in seconds) to find the platform of khat and
ketamine treated mice was significantly higher (p < 0.05) when compared to CON.
Conclusions: Subchronic oral administration of khat showed an enhanced locomotor activity, reduced social
interaction and impaired cognitive function, which demonstrated that long-term use of khat is associated with
schizophernic-like symptoms.
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Background
According to World Health Organization (WHO) defin-
ition, schizophrenia is a severe mental disorder, charac-
terized by profound disruptions in thinking, affecting
language, perception, and the sense of self and it affects
more than 21 million people worldwide [1]. Since no
biological marker for schizophernia has yet been found,
diagnosis is based on the assessment of the symptoms of
each patient [2]. Different studies have shown that khat
chewing is associated with occurrence of psychotic
symptoms [3, 4].
Chewing the fresh leaves and shoots of the ever green
plant khat (Catha edulis) dates back several centuries in
eastern and southern Africa and the Arabian Peninsula
[5]. Nowadays, it is estimated that 20 million people
worldwide chew khat regularly to enjoy its psychostimu-
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Studies have shown that neurocognitive impairments
[5], euphoria, excitability, anxiety, and insomnia [7, 8],
are some of central nervous system effects of khat chew-
ing. Khat chewing can also induce psychological depend-
ency [5, 9, 10].
The main psycho-active component of khat leaves is
cathinone (S-(−)alpha-aminopropiophenone) [11]. Cathi-
none resembles amphetamine in chemical structure and
affects the central and peripheral nervous system [12, 13]
and behavior [14, 15]. Similarly amphetamine and some of
its derivatives have been shown to induce psychotic symp-
toms in experimental settings in humans [16, 17] and ani-
mals [18] and have been known to exacerbate psychotic
states in psychiatric patients [19, 20].
To the best of our knowledge, the relationship be-
tween use of khat and psychiatric problems has been lit-
tle explored in population-based studies. It has been
postulated that khat use can exacerbate psychotic symp-
toms in individuals with pre-existing conditions, and
precipitate psychiatric disorders in vulnerable subjects
[14]. Moreover, khat consumption may affect the course
of a psychotic disorder [16, 17].
Establishment of animal models of schizophrenia is crit-
ical for both understanding the mechanisms underlying se-
vere mental disease and developing new antipsychotics
[21]. There are various animal models of schizophrenia
which seek to replicate the symptoms that are observed in
human schizophrenics [21]. However, it has been difficult
to find a particular model that is able to completely repli-
cate all the symptoms observed in humans. In animal
models, hyperactivity is considered as representative of
positive symptoms in humans. Social withdrawal is consid-
ered to be the animal version of negative symptoms [21].
The current animal study was conducted in order to
show interaction between khat use and schizophernia as
there is no large-scale studies examining the relationship
between effect of khat and schizophrenic-like symptoms.
Therefore, the aim of this study was to evaluate
schizophrenic-like symptoms of subchronic oral admin-
istration of crude khat extract in mice.
Methods
Drugs and chemicals
Diethyl ether and chloroform (Sigma-Aldrich, Germany),
ketamine (Trittau, Germany) and 70 % ethanol (Pharma-
ceutical Fund Supply Agency (PFSA), Addis Ababa,
Ethiopia) were purchased from the respective local vendors.
Animals
Adult Albino mice bred in the animal house of the
School of Pharmacy, Addis Ababa University and having
weights ranging from 25 to 35 g and 8 weeks of age were
used for the experiment. The animals were housed in
groups of six in plastic wire meshed cages in the animal
house. Wooden material used as bedding was replaced
every 3 days. The animals were allowed free access to
tap water and standard laboratory pellet. The environ-
mental conditions were kept normal (25 ± 1 °C, and
12 h/12 h light/dark cycle). The study was approved by
the Institutional Animal Care and Use Committee of
School of Pharmacy, Addis Ababa University, Ethiopia
and the care and handling of mice were done in accord-
ance with the internationally accepted standard guide-
lines for use of animals [20].
Plant material
Bundles of Catha edulis forsk shoots and small branches
(about 8000 g) were purchased fresh at a local market in
“Aweday”, one of the common natural habitat, which is
located about 500 km away from Addis Ababa, in the
Eastern part of Ethiopia. The bundles of khat plant were
collected in December 2011 where large amounts of
khat plant come to the local market. The fresh bundles
were packed in plastic bags and transported in an ice
box to the laboratory. The fresh leaves were immediately
kept in a deep freezer (−20 °C). The plant was identified
by a taxonomist and a voucher specimen was deposited
in the National Herbarium, College of Natural Sciences,
Addis Ababa University under a voucher Number 001.
Preparation of plant extracts (crude extract)
The extract was prepared as described by Connor et al.
[22]. The leaves were finely chopped in a dark place,
weighed and placed in an Erlenmeyer flask containing
reagent grade chloroform and diethyl ether in a 1: 3 v/v
ratio. The volume of the combination of these volatile
solvents used was more than that needed to just cover
the minced leaves in the flask; hence a total of 400_ml
solvents (100_ml of chloroform and 300_ml of diethyl
ether) used for 200_g of the chopped leaves and shoots.
The mixture of khat plant with the solvent system was
shaken using rotary shaker (120 rev/min) for two days
under controlled temperature (20°c). The extract was dec-
anted and filtered with Whatman No. 1 filter paper. The
extract was placed in a hood under pressure for a week
and then dried using Lyophilizer (Operan, Korea). Extracts
were kept covered with aluminum foil and refrigerated.
Induction of schizophernia
A study has shown that the most representative animal
model of schizophrenic dysfunction seems to be those
involving the administration of N-methyl-D-aspartic acid
(NMDA) antagonist. Thus animals which were treated
with NMDA antagonists e.g., ketamine could be used as
a model of several aspects of schizophrenic dysfunction
in humans [21]. Accordingly, Albino mice were injected
intraperitoneally with 10 mg/kg ketamine for consecu-
tive 14 days.
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Experimental design
A total of 60 albino mice were utilized and the
animals were randomly divided into 5 groups of 12
animals (6 mice housed per cage) in each group.
Group I- Normal mice (received the vehicle, 2 % v/v
Tween-80 in distilled water, p.o [CON])
Group II- Schizophernic control (received ketamine
10_mg/kg, i.p [KT10])
Group III- Khat treated (received 100_mg/kg, p.o
[K100])
Group IV- Khat treated (received 200_mg/kg, p.o
[K200])
Group V- Khat treated (received 400_mg/kg, p.o
[K400])
The extract was administered to the respective groups
through oral route using intragastric tube (gavage) for
60 days. Such route was used since pharmacokinetics
studies showed that C. edulis or S-(−)-cathinone is read-
ily absorbed into plasma from the stomach and mouth
[23, 24]. Besides, C. edulis leaves are usually taken orally
in humans. Throughout the experimental period, all ex-
tract solutions were made fresh and containers including
syringes were covered with aluminum foil to avoid light
decomposition. On each day of the experiment, experi-
mental mice were taken from their cage and weighed
using electrical digital balance with 0.01 precision, since
the weight of animals was necessary to determine the
doses of khat extract.
Dose selection was made based up on a previous study
done by Admassie et al. [25]. The dose of the extract re-
quired was determined based on the weight of the mice.
Total weight of mice taking similar dose of extract was
determined for ease of dose calculation. Once total
amount of extract administered was calculated, the ex-
tract was reconstituted with 2 % v/v Tween-80 in dis-
tilled water. The volume of reconstitution fluid was
adjusted, so that the maximum volume administered
should not normally exceed 1 ml at a time for individual
mouse in accordance with the Organization for Eco-
nomic Co-operation and Development (OECD) guide-
lines for the testing of chemicals No. 413 ‘routes of
exposure and dose administration considerations’: (as re-
vised in 2010). CON group received only the reconstitu-
tion fluid based on their weight. This procedure was
repeated every day for 60 days of experiment.
Timeline of the study design
After mice were administered crude khat extract for 60
consecutive days, they were subjected to a battery of be-
havioural tests (locomotor activity study, social inter-
action study and cognitive function study). During all
the behavioural studies, no extract treatment was given.
For each of the behavioral studies, 6 animals were uti-
lized at a time out of 12 animals from their respective
groups (CON, KT10 and khat treated). Hence, the same
mice were utilized in different behavioural studies at dif-
ferent time.
Locomotor activity study
The Linton instrumentation Activity Monitor (AM1053)
(Palgrave, North folk), computer software coupled de-
vice, is used to record the activity score of mice. The de-
vice operates using an array of infrared beams and
detectors.
Two activity boxes were placed in a quiet room. The
boxes were transparent polycarbonate cages, which were
similar to the home cages but were each equipped with
48 infrared beams, 24 on each level arranged in an 8x16,
1” (25.4_mm) pitched grid. A computer detected the dis-
ruption of the infrared beams and recorded the number
of beam breaks. This beam breaks were considered as
measures of locomotor activity.
Mice were habituated for two days to the testing room
and the testing boxes (30 min/day for 2 days). Following
habituation on day 1, mouse was placed into the loco-
motor activity boxes for 20 min and locomotor activity
(number of infrared beam breaks) was measured. After
each group study, the activity boxes were cleaned by
70 % ethanol to avoid any potential cues and make the
activity box ready for the other group study. This pro-
cedure was repeated for another 4 days (a total of 5 test-
ing days).
Social interaction study
The apparatus used for the detection of changes in social
behavior consists of an open-topped apparatus (51 ×
51 cm and 20 cm high). Mouse used in this study was
housed individually for 5 days. Mice were marked with
different colours to distinguish the different groups and
placed into the box (with 60 W bright illumination
17 cm above and video camera mounted above so as to
view the entire apparatus).
One mouse from each group was taken at a time and
social activity studies were done for each mouse indi-
vidually over a 10- minute period by remote video re-
cording. Once social activity study was done for a group,
the open-topped box was cleaned with 70 % ethanol to
avoid any potential cues and make the box ready for the
other group study.
Total time spent in social interaction, total time spent
sniffing and following a partner within an inch and half
were also determined in the present study. Total time
spent in social interaction was determined by timing the
sniffing of partner, crawling under or climbing over the
partner, genital investigation of partner and following
the partner. Total time spent sniffing and following a
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partner were determined by timing the sniffing and fol-
lowing of the partner within an inch and half
respectively.
Cognitive study
Morris water maze (MWM) was used to evaluate cogni-
tive function [26]. MWM consisted of a circular pool
(122 cm diameter and 76 cm depth) in which mice were
trained to escape from water by swimming to a hidden
platform (1.5 cm beneath water surface) whose location
could be only identified using distal extra-maze cues
attached to the room walls. Different 3-D shapes that
can act as visual cues were kept at constant location dur-
ing the whole experiment. Water temperature was main-
tained at 21 ± 1 °C. The platform was placed in the
middle of the North-West (NW) quadrant and remained
at the same position during the whole experiment.
Acquisition phase study
The spatial acquisition phase consisted of 16 training
trials: 4 training trials per day and 4 training days with
an inter-trial interval of 20 min. Mice were released ran-
domly with their heads facing the pool wall from the
four compass locations (NE, NW, SW, and SE), and
allowed to swim and search for the platform for 120 s. If
mice did not locate the platform after 120 s, animals
were manually placed on the platform and allowed to
remain on it for 30 s so that learning had to occur.
On the first training day, mice were given an
acclimatization training session in the water maze by
placing on the hidden platform and after acclimatization,
mice were allowed to swim for 30 s and the latency to
reach the hidden platform was recorded. And, if the
mice were unable to found the hidden platform, they
were guided back to the platform. This study was done
for another 3 days (a total of 4 days) and the latency to
reach the hidden platform in each day was recorded.
Short-term memory retention phase study
One day after the acquisition phase (i.e., on day 5), sub-
jects received a probe trial, in which the platform was
removed. Mice were released from the NW start point
and were allowed to swim freely for 60 s. Time spent in
target quadrant (where the platform was located) was
recorded.
Long-term memory retention phase study
On the 12th day, subjects once again received the
probe trial for 60 s to check retention of memory.
Mice were released from the NW start point and
were allowed to swim freely for 60 s. Time spent in
target quadrant was recorded. Mice didn’t receive
training between 5 and 12 days.
Statistical analysis
Statistical analysis was performed using SPSS software
package, Version 20.0. All the data were expressed as
mean ± SEM. In order to study locomotor activity and
social interaction among groups of mice, one way with
Tukey’s procedure and repeated measures of ANOVA
were utilized while for the study of cognition, one way
repeated measure of ANOVA and paired sampled t-test
was used. The value of p < 0.05 was considered to be
statistically significant.
Results
Locomotor activity among groups of mice
A one-way analysis of variance (ANOVA) was conducted
to compare the locomotor activity scores of control, khat
treated and ketamine groups of mice after subchronic
crude khat extract administration daily for 2 months.
ANOVA test indicated that there was a significant differ-
ence in the mean locomotor activity scores (across the
five test days) of control groups (CON and KT10) and
khat treated groups of mice (K100, K200 and K400) (F
(4, 25) =136.17, p < 0.001) (Fig. 1).
A one-way repeated measures ANOVA was also con-
ducted to compare the mean locomotor activity score of
khat treated and ketamine groups of mice during the
20 min trial in the device across the five test days. There
was a significant effect for days, Wilks’ Lambda = 0.58, F
(4, 22) = 3.94, p = 0.015, multivariate partial squared =
0.42. This result suggest that the mean locomotor activ-
ity score of khat treated and ketamine groups of mice
had significant effect for days.
Repeated measure of ANOVA also revealed that
there was a significant effect between groups (CON
and khat treated) of mice, F (4, 25) =135.82, p <
0.001. However, within-groups (days* group) effect of
mean locomotor activity score was not significant, F
(16, 100) = 1.25, p =0.246. This means that the mean
locomotor activity score of each mice within respect-
ive groups of mice were not significantly different
across the five test days.
Social interaction
Total time spent in social interaction
A one-way analysis of variance was conducted to com-
pare the total time spent in social interaction scores of
control, khat and ketamine treated groups of mice after
subchronic crude khat extract administration daily for
2 months.
ANOVA test indicated that there was a significant
difference in the mean total time spent in social inter-
action scores of control groups (CON and KT10) and
khat treated groups of mice (K100, K200 and K400) (F
(4, 25) =244.16, p < 0.001) (Fig. 2).
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Total time spent sniffing the partner
A one-way analysis of variance was conducted to com-
pare the total time spent in sniffing scores of control,
khat treated and ketamine groups of mice after sub-
chronic crude khat extract administration daily for
2 months. ANOVA test indicated that there was a sig-
nificant difference in the mean total time score spent in
sniffing partner within an inch and half of control
groups (CON and KT10) and khat treated groups of
mice (K100, K200 and K400) (F (4, 25) = 126.23, p <
0.001) (Fig. 3).
Pairwise comparisons of mean total time score (seconds)
spent sniffing partner showed that when the different doses
of crude extracts were compared to each other, the highest
dose, K400, resulted in the lowest total mean time score
spent in sniffing the partner compared to K200 (p = 0.014)
and K100 doses (p < 0.001). However, pairwise comparisons
among K200 and K100 doses were not significant (p= 0.57).
Total time spent following a partner
A one-way analysis of variance was also conducted to
compare the total time score spent in following a
Fig. 1 Mean locomotor activity score of groups of mice during the 20 min trial in the Activity Device Monitor across the five test days
(n = 6/group). Data analysis were done by using Tukey’s procedure. **p < 0.001, indicates level of significance relative to controls (CON)
Fig. 2 Mean total time score (in seconds) spent in social interaction among groups of mice over the 10 min video recording in open-topped box
(n = 6/group). Pairwise comparisons revealed that the khat extract dose-dependently decreased the mean total time spent in social interaction
(p < 0.001). *p < 0.001, indicates level of significance relative to controls (CON)
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partner of control, khat treated and ketamine groups
of mice after subchronic crude khat extract adminis-
tration daily for 2 months. ANOVA test indicated
that there was a significant difference in the mean
total time score spent in following partner of control
groups (CON and KT10) and khat treated groups of
mice (K100, K200 and K400) (F (4, 25) = 115.60, p <
0.001) (Fig. 4).
Pairwise comparisons of mean total time score (sec-
onds) spent following partner demonstrated that com-
parisons among different doses of the extract on the
mean total time score spent following the partner re-
vealed that the decrease was dose-dependent. Accord-
ingly, K400 resulted in the lowest total mean time
score spent in following the partner compared to
K200 (p = 0.002) and K100 doses (p < 0.001). However,
pairwise comparisons among K200 and K100 doses
were not significant (p = 0.10).
Cognition
The present results demonstrated the performance of
khat treated and control groups of mice in water based
spatial task. All groups of mice learned the task in the
MWM within 16 trials. During the training most of khat
as well as ketamine treated groups of mice preferred the
edge of the wall and circled swimming in the direction
submerged. In identification of the hidden platform, khat
treated and ketamine groups of mice were able to touch
the platform but unable to climb.
Fig. 3 Mean total time score (in seconds) spent in sniffing partner within an inch and half of groups of mice over the 10 min video recording in
open-topped box (n = 6/group). *p < 0.001; indicates level of significance relative to controls (CON)
Fig. 4 Mean total time score (in seconds) spent in following partner within an inch and half of groups of mice over the 10 min video recording
in open-topped box (n = 6/ group). *p < 0.001, indicates level of significance relative to controls (CON)
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Acquisition phase
The performance of acquisition phase was confirmed by
applying the general linear model: repeated measures of
ANOVA between the latency to reach the hidden plat-
form and days of trials. The mean latency score of each
group of mice during each test days are presented in
Fig. 5. There was a significant effect for days, Wilks’
Lambda = 0.56, F (3, 23) = 6.14, p = 0.003, multivariate
partial squared = 0.45. This result suggest that the mean
latency score of khat treated and ketamine groups of
mice had significant effect for days.
Repeated measure of ANOVA also revealed that there
was a significant effect between groups (CON and khat
treated) of mice, F (4, 25) =351.20, p < 0.001, multivari-
ate partial squared = 0.98. Likewise, within-groups (days*
group) effect of mean latency score to reach the hidden
platform was significant, F (12, 75) =9.71, p < 0.001,
multivariate partial squared = 0.61. This means that the
mean latency to reach the hidden platform of each mice
within respective groups of mice were significantly dif-
ferent across the five test days.
The mean difference between the latency score to
reach the hidden platform on day1 and day 4 (ΔL) was
calculated for each khat treated and controls groups of
mice in order to study their ability to learn the task. The
means and SEM are presented in Table 1. One way
ANOVA analysis indicated that there was a significant
difference in the mean latency score to reach the hidden
platform of CON and other groups of mice (K100, K200,
K400 and KT10) (F (4, 25) = 26.73, p < 0.001). This indi-
cated that CON group learns the task but other groups
of mice failed to learn the task.
Short-term memory retention phase
During the probe trial on day 5, time (in seconds) spent
in the target and in the adjacent quadrants was analyzed
using paired sample t-test and repeated measure of
ANOVA. The result of the repeated measures of
ANOVA indicated that there was a significant effect for
quadrant (either target or adjacent quadrant) prefer-
ences, (Wilks’ Lambda = 0.03, F (4, 25) = 960.20, p <
0.001, multivariate partial squared = 0.98).
The paired sample t-test (for each group separately)
was also performed to confirm that the preference
between the mean time score spent in the target and
adjacent quadrants among different groups of mice. Ac-
cordingly, CON group of mice spent significantly more
time in target quadrant (p < 0.001, t = 16.94) (Mean =
37.12, SEM = 1.17, N = 6) compared to adjacent quadrant
(mean = 17.40, SEM = 0.00, N = 6). The increase was
19.77, with 95 % confidence interval between the means
of 16.77 to 22.77 while K100 (t = 3.67, p = 0.014), K200
(t = 18.04, p < 0.001), K400 (t = 18.69, p < 0.001) and
KT10 (t = 46.71, p < 0.001) groups of mice significantly
spent more time in adjacent quadrant (See Fig. 6).
Long-term memory retention phase
During the probe trial on day 12, time (in seconds) spent
in the target and in the adjacent quadrants was analyzed
using paired sample t-test and repeated measure of
ANOVA. The result of the repeated measures of
ANOVA indicated that there was a significant effect for
quadrant (target and adjacent quadrants) preferences,
(Wilks’ Lambda = 0.06, F (4, 25) = 366.04, p < 0.001,
multivariate partial squared = 0.94).
The paired sample t-test (for each group separately)
was also performed to confirm that the preference be-
tween the mean time score spent in the target and adja-
cent quadrants of different groups of mice. Accordingly,
CON groups of mice spent significantly more time in
target quadrant (p < 0.001, t = 6.73) (Mean = 34.33,
SEM = 1.58, N = 6) compared to adjacent quadrant
(mean = 23.67, SEM = 0.00, N = 6). The increase was
10.66, with 95 % confidence interval between the means
of 6.59 to 14.74 while K100 (t = 6.95, p = 0.001), K200
(t = 20.43, p < 0.001), K400 (t = 38.33, p < 0.001) and
Fig. 5 Mean latency score to reach the hidden platform (acquisition phase) among groups of mice over the period of four days of water maze
trials (n = 6/ group)
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KT10 (t = 66.48, p < 0.001) groups of mice significantly
spent more time in adjacent quadrant (See Fig. 7).
Discussion
This study described the schizophrenic-like symptoms of
subchronic (two months) oral administration of crude
khat extract (Catha edulis forsk) in mice using battery of
behavioural tests (locomotor activity study, social inter-
action study and cognitive function study). The study
revealed that subchronic oral administration of crude
khat extract daily resulted in dose-related neurobeha-
vioural abnormalities, including locomotor hyperactivity,
abnormal social behavior and decreased cognition. These
abnormal behaviors in mice are thought to be correlates
of the symptoms of schizophrenia [27].
In this study, the mean locomotor activity score of
mice treated with khat was significantly higher com-
pared to control (p < 0.001) whereas it was significantly
lower compared to ketamine treated groups of mice (p <
0.001). The tendency of increased locomotor activity with
khat administration is concordant with previous studies
[28, 29]. This phenomenon is assumed to be due to
neurotransmitter systems, including dopamine and sero-
tonin, as locomotor activities are modulated by these
neurotransmitters. Cathinone, the active compound of khat
is associated directly and/or indirectly with dopamine or
serotonin release by its action on dopamine or serotonin
transporter function [29, 30]. Further, it has been demon-
strated that the motor activities induced by S – (−)
cathinone in experimental animals are associated with
dopamine release [29].
Habituation refers to a decrease in response that is
observed when an identical stimulus is presented repeat-
edly and it is considered to be the simplest form of
learning [31]. Interestingly, a deficit in this form of non-
associative learning has been demonstrated in this study
and the mean locomotory effect of control mice across
the five test days decreased while this was not true for
khat and ketamine treated mice. This might be probably
because of control mice developed habituation of the
device within test days. However, for those groups
treated with khat and ketamine, the observed effect
might be due to either neurochemical effect outweighs
habituation of the activity device monitor or there was a
deficit in non-associative learning.
Results from current study showed that subchronic oral
administration of crude C. edulis extract induced the
locomotor-activity in a dose-dependent manner. This
finding is concordant with earlier study that demonstrated
animals behave in the same way when administered cathi-
none as if they had been given (+)-amphetamine, and the
response was dose related [32]. Animal study has also
shown that repeated administration of amphetamine-like
stimulants result in altered behavioural responses like
behavioural sensitization [33]. Behavioural sensitization
occurs when repeated treatment with psychostimulant
drugs produces alteration in the behaviour that outlasts
the initial neuropharmacological actions [33]. In this
Fig. 6 The mean time score spent in target and adjacent quadrants among different groups of mice during the probe trial on Day 5
(n = 6/ group). *p < 0.05, **p < 0.001; indicates level of significance for each group separately
Table 1 The difference between mean latency score to reach
the hidden platform on day 1 and day 4
Groups of mice Mean ± SEM N
CON 16.83 ± 1.08 6
K100 −1.17 ± 0.54 6
K200 −1.17 ± 2.0 6
K400 −0.17 ± 2.33 6
KT10 −1.0 ± 0.77 6
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regard, khat extract in current study might exhibit behav-
ioural sensitization on locomotion, ultimately leading to
locomotor sensitization.
Psychosis and behavioural sensitization in laboratory ani-
mals are frequently correlated [34]. Therefore, in this study,
the phenomenon of locomotor sensitization induced by C.
edulis extract or ketamine in mice may bear striking simi-
larities to the progressive development of psychosis in
human. For example, different clinical studies revealed the
association between repeated C. edulis chewing and psych-
osis [14, 15, 35]. Hence, the use of psychostimulants is often
associated with a higher risk of psychosis [36, 37]. Taken
together, the capacity of C. edulis to elicit a long-lasting
behavioural sensitization supports the anecdotal reports
about psychiatric problems which was associated with
C. edulis chewing [15, 38]. Recently, it is also argued
that organophosphates (through the exposure of khat
to pesticides during or after cultivation) and high
level of free radicals that could be linked directly to
the effects of the khat constituents, cathinone and
cathine, are important confounders in khat chronic
consumption and psychosis symptoms in human [39].
It’s known that social withdrawal is considered to be
the animal version of negative symptoms of schizophre-
nia [21]. The present study revealed the mean total time
score spent in social interaction of khat and ketamine
treated mice was significantly lower than control
groups. Thus, khat treated groups were socially iso-
lated than controls taking the vehicle but ketamine
treated mice were highly isolated socially. This result
is in line with the fact that schizophrenics experience
symptoms subtracted from normal behaviour or func-
tion, for example social withdrawal, blunted affect
and lack of motivation [21].
The current study also showed that after subchronic oral
administration of crude C. edulis extract, the mean time
(sec) spent in social interaction decreased in a dose
dependent manner. This may be possibly explained because
of khat-induced over stimulation of D2 receptors resulted
in hypostimulation of D1 receptors which has been sug-
gested to be in part responsible for negative symptoms of
schizophrenia [40]. Furthermore, since the seminal work of
Pycock et al.[41], many laboratories result have described
reciprocal and opposite regulations between D2 and D1
systems. Hence, higher khat-induced over stimulation of
D2 receptors because of the higher dose of crude khat
extract administered (400 mg/kg) in current study may
resulted in greater hypostimulation of D1 receptors.
According to Kwon et al., unfamiliar mice placed in a
neutral arena will usually display high levels of sniffing
and following [42]. In contrary, the results from this
study indicated that time spent sniffing and following
the partner within an inch and half showed decrement
in a dose- dependent manner. This may possibly due to
lack of motivation of mice taking the extract to investi-
gate unfamiliar mice in the open box chamber indicating
subtracted symptoms from normal behavior.
Since its first application in 1981, the MWM has be-
come one of the most frequently used tool for analyzing
spatial learning and memory [26]. The tool is known for
its basic training protocols that include hidden-platform
acquisition training, probe trial testing and working
memory testing [26].
Our results indicate that there was mean improvement
in overall performance of control mice in spatial learning
whereas khat and ketamine treated mice showed very
poor learning during the period of training. During the
hidden-platform acquisition training, control mice learned
the task with decreased latencies across time indicating
mean improvement in the animal’s performance. The dif-
ference in latency to reach the platform between Day 1
and Day 4 was significantly higher in the controls
Fig. 7 The mean time score spent in target and adjacent quadrants among different groups of mice during the probe trial on Day 12
(n = 6/ group). *p < 0.01, **p < 0.001; indicates level of significance for each group separately
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indicating ability to learn the task. However, no significant
learning was observed for either khat or ketamine treated
mice during acquisition phase because of they showed no
significant latency differences in the trials. This finding is
consistent with a study that examined impaired cognitive
function such as deficits in performance in spatial alterna-
tion tasks using ketamine in laboratory animals as com-
pared to controls [43].
Previous preliminary observation of khat use suggests
that chronic khat use is implicated with various cogni-
tive and mental health impairments [18, 38]. However,
extensive study on the effect of khat use on learning and
memory is lacking. Therefore, the effect of khat use on
learning and memory is usually deducted from studies
made on other substances with close structural and
functional similarity with the active constituent of khat.
Amphetamine is the substance with close similarity to
the active constituent of khat, cathinone [28]. A review
by Warfa et al., indicated that chronic use of amphet-
amine leads to impairment on learning and memory, for
instance, negative effect on episodic memory, working
memory and a delay in the organizational and technical
component of memory encoding [18].
In this study after a series of acquisition trial blocks, a
probe or transfer trial at day 5 is usually performed to
determine the spatial accuracy of the animal which is
represented by the time it spends looking for the plat-
form in the quadrant where the platform used to be (tar-
get quadrant) [44]. Accordingly, in the current study
control group spent more time in target quadrant while
K100, K200, K400 and KT10 groups spent more time in
adjacent quadrants indicating that khat extract resulted
in impairment of spatial accuracy to determine where
the platform was used to be. The current study also indi-
cated impairment in long term memory after probe trial
at day 12 in MWM task. These all might be possibly re-
sulted from the nature of cathinone. In CNS cathinone
provokes the release of catecholamines especially dopa-
mine at synaptic storage sites and results in overall
stimulation of D2 receptors. This stimulation inhibits
NMDA-mediated glutamate transmission and long term
potentiation [45]. Also it is clear that glutamate and
dopaminergic system are known to modulate each
other’s activity in reciprocal fashion [46].
Conclusions
Looking at the data produced in the present study, sub-
chronic oral administration of crude khat extract re-
sulted in enhanced motor activity in ADM study,
symptoms subtracted from normal behavior of mice in
open box chamber study and cognitive deficit in MWM
study. Based on these findings, subchronic oral adminis-
tration of crude khat extract (Catha edulis forsk) in-
duces schizophernic-like symptoms in mice.
Abbreviations
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